Evidence map›Paper›PMID 32115406›Full record

ArticleGenes & development2020

Critical roles of phosphoinositides and NF2 in Hippo pathway regulation.

Audrey W Hong, Zhipeng Meng, Steven W Plouffe, Zhijie Lin, Mingjie Zhang, Kun-Liang Guan

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. The Hippo signalling pathway and its impact on eye diseases.Journal of cellular and molecular medicine · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.bioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Audrey W HongDepartment of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.
Zhipeng MengDepartment of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.
Steven W PlouffeDepartment of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.
Zhijie LinDivision of Life Science, State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, China.
Mingjie ZhangDivision of Life Science, State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, China.
Kun-Liang GuanDepartment of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla, California 92093, USA.
University of California San Diego · USHong Kong University of Science and Technology · HK

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
PROTEIN PHOSPHORYLATION AND GROWTH FACTOR FUNCTIONR01GM051586 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROWN, JOAN HELLER · 1994 to 2024
$7.9M
The mTOR and Hippo pathway in cell growth and cancerR35CA196878 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUAN, KUN-LIANG · 2015 to 2019
$4.0M
NCI NIH HHS P30 CA023100NCI NIH HHS R35 CA196878NIGMS NIH HHS R01 GM051586NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

The Hippo pathway is a master regulator of tissue homeostasis and organ size. NF2 is a well-established tumor suppressor, and loss of NF2 severely compromises Hippo pathway activity. However, the precise mechanism of how NF2 mediates upstream signals to regulate the Hippo pathway is not clear. Here we report that, in mammalian cells, NF2's lipid-binding ability is critical for its function in activating the Hippo pathway in response to osmotic stress. Mechanistically, osmotic stress induces PI(4,5)P

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsCell LineHippo Signaling PathwayHomeostasisHumansMiceNeurofibromin 2Osmotic PressurePhosphatidylinositolsPhosphorylationProtein Serine-Threonine KinasesYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingCell Cycle ProteinsNeurofibromin 2PhosphatidylinositolsProtein Serine-Threonine KinasesYap1 protein, mouseYAP-Signaling ProteinsHippo pathwayNF2phospholipids

Identifiers

PMID32115406
PMCPMC7111263
OpenAlexW3008151072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.